Longitudinal Pulmonary Outcomes After Posterior Spinal Fusion in Duchenne Muscular Dystrophy: A Retrospective Cohort Study

For many people, the spine is simply the sturdy column that holds us upright, but for those living with Duchenne muscular dystrophy, a genetic condition that causes muscles to weaken over time, the body's architecture faces a unique challenge. As the muscles that support the skeleton fade, the spine often begins to curve sideways, a condition known as scoliosis. This curve does more than just change how a person sits; it can twist the rib cage and squeeze the space available for the lungs to expand. In the later stages of the disease, when walking is no longer possible, the lungs naturally become weaker on their own, and the added pressure from a curved spine can make breathing even harder. This creates a difficult question for doctors and families: if surgeons straighten the spine with metal rods and screws, will that mechanical fix also save the lungs from failing, or is the breathing trouble caused by something the surgery cannot reach?

A team of researchers at Nationwide Children's Hospital set out to answer this question by looking back at the medical records of sixteen young men with Duchenne muscular dystrophy who had undergone this specific surgery, known as posterior spinal fusion. These patients were all non-ambulatory, meaning they were no longer able to walk, and they were an average age of nearly eighteen when the operation took place. The researchers did not just look at how straight the spine became; they carefully tracked the patients' breathing capabilities at three distinct moments: before the surgery, about five to six months after the operation, and again roughly two years later. They measured how much air the patients could force out of their lungs in one breath and how hard their breathing muscles could push or pull, comparing these numbers over time to see if the surgery had changed the natural course of their respiratory decline.

The results painted a clear, if somewhat sobering, picture of what happens after the surgery. In the months immediately following the operation, the patients' lung function appeared to hold steady. The percentage of lung capacity predicted for a healthy person of their size did not drop significantly between the pre-surgery check and the five-to-six-month mark. However, by the time the two-year follow-up arrived, that stability had given way to a noticeable decline. The average lung capacity had dropped by nearly nine percentage points from where it started, returning to the expected pattern of gradual weakening seen in the disease itself. The study also found that the breathing muscles, specifically the ones used to exhale forcefully, took a hit right after the surgery, likely due to the physical stress of the operation and the pain that follows, though they showed some recovery by the two-year mark.

Perhaps the most surprising discovery challenged a common hope held by many families and surgeons: that correcting the curve more aggressively would lead to better breathing outcomes. The researchers found the opposite to be true. The patients who received the most dramatic straightening of their spine, where the doctors corrected the largest amount of the curve, actually experienced the greatest loss in the actual volume of air they could breathe out. This suggests that the severity of the spinal deformity is not the primary enemy of the lungs in this condition. Instead, the decline in breathing seems to be driven almost entirely by the progressive weakness of the respiratory muscles themselves, a biological process that surgery cannot stop. The amount of correction did not seem to influence the percentage of predicted lung capacity, but the sheer magnitude of the straightening was linked to a larger drop in the raw volume of air measured.

The study also looked at whether medications played a role in these outcomes. Most of the patients had taken corticosteroids, a standard treatment for the disease, but because almost everyone in the group had taken them, the researchers could not draw a firm conclusion about their specific effect on post-surgery breathing. However, they did notice a pattern regarding another type of medication called bisphosphonates, which are often used to strengthen bones. The patients who had received these drugs showed a sharper drop in lung function in the first few months after surgery compared to those who had not. The authors suggest this might not be a direct side effect of the drug, but rather a sign that those patients had more severe disease or more cumulative damage from their condition, making them more vulnerable to the stress of the operation.

Ultimately, this research offers a vital clarification for the goals of spinal surgery in Duchenne muscular dystrophy. While the procedure successfully straightens the spine and improves sitting balance, it does not appear to act as a shield against the inevitable weakening of the lungs. The findings indicate that the primary driver of respiratory failure in these patients is the disease's attack on the muscles, not the mechanical restriction of the chest wall. Therefore, the decision to undergo spinal fusion should be framed around the tangible benefits of improved posture, comfort, and ease of care, rather than the expectation of preserving lung function. The surgery fixes the structure, but it cannot halt the underlying biological decline, a distinction that helps families and doctors set realistic expectations for the future.